Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
暂无分享,去创建一个
D. Gerding | E. Dubberke | G. Rahav | D. Kao | Christine H. Lee | C. Kelly | M. Ellison | M. Dorr | D. Guris | B. Yacyshyn | M. Hanson | K. Eves | Princy N. Kumar